Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36940
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Hulten, Veerle-
dc.contributor.authorSarodnik, Cindy-
dc.contributor.authorDriessen, Johanna H. M.-
dc.contributor.authorSchaper, Nicolaas C.-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorWebers, Carol A. B.-
dc.contributor.authorDinant, Geert-Jan-
dc.contributor.authorOttenheijm, Ramon P. G.-
dc.contributor.authorRasmussen, Nicklas H.-
dc.contributor.authorViggers, Rikke-
dc.contributor.authorStehouwer, Coen D. A.-
dc.contributor.authorVAN DER KALLEN, Carla-
dc.contributor.authorSchram, Miranda T.-
dc.contributor.authorBours, Sandrine P. G.-
dc.contributor.authorDagnelie, Pieter C.-
dc.contributor.authorVAN DEN BERGH, Joop-
dc.date.accessioned2022-03-21T08:41:02Z-
dc.date.available2022-03-21T08:41:02Z-
dc.date.issued2022-
dc.date.submitted2022-03-18T09:53:53Z-
dc.identifier.citationFrontiers in Endocrinology, 13 (Art N° 832977)-
dc.identifier.urihttp://hdl.handle.net/1942/36940-
dc.description.abstractBackgroundType 2 diabetes (T2D) is frequently reported to be associated with an increased fracture risk. Epidemiological data on prevalent morphometric vertebral fractures (VFs) in T2D are sparse and even less is known in the prediabetic state. PurposeTo determine the association between prevalence and severity of morphometric VFs and glucose metabolism state: normal glucose metabolism (NGM), impaired glucose metabolism (prediabetes) or T2D. MethodsThis study included cross-sectional data from 3625 participants of the Maastricht Study who had a vertebral fracture assessment on lateral Dual Energy X-Ray Absorptiometry images. VFs were classified based on morphometric assessment into mild, moderate and severe VFs (respectively 20-24%, 25-39% or >= 40% reduction in expected vertebral body height). Logistic regression models were used to investigate the association between glucose metabolism status and the prevalence and severity of VFs. Analyses were adjusted for subject characteristics and life-style factors. ResultsT2D individuals were older (62.8 +/- 7.5 years old) and less often female (30.5%) compared to the NGM group (57.7 +/- 8.5 years old, and 58.8% female, respectively). At least one mild, moderate or severe prevalent VF was found in 8.6% of the men and 2.2% of the women in the T2D group, in 9.4% and 8.4% in the prediabetes group and in 9.1% and 4.8% in the NGM group, respectively. After adjustment T2D in women was associated with a lower probability of having a prevalent VF compared to NGM [adjusted OR 0.25 (95% CI 0.09-0.65)], while this was not the case for prediabetes. Furthermore, women with T2D had a significantly lower probability of a prevalent moderate or severe VF [adjusted OR 0.32 (95% CI 0.11-0.96)]. In men there was no significant association between T2D or prediabetes and prevalent VFs. ConclusionWomen with T2D had a lower probability of prevalent VFs compared to women with a normal glucose metabolism, while this was not the case for men with T2D and participants with prediabetes.-
dc.description.sponsorshipThis study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), CAPHRI School for Public Health and Primary Care (Maastricht, the Netherlands), NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands), Perimed (Järfälla, Sweden), and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands), and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). VH received research funding from Novo Nordisk (Steno Collaborative Grant 2018). The authors would like to thank all participants and staff involved in The Maastricht Study. Preliminary results were presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting.-
dc.language.isoen-
dc.publisherFRONTIERS MEDIA SA-
dc.rights2022 van Hulten, Sarodnik, Driessen, Schaper, Geusens, Webers, Dinant, Ottenheijm, Rasmussen, Viggers, Stehouwer, van der Kallen, Schram, Bours, Dagnelie and van den Bergh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.-
dc.subject.otherbone-
dc.subject.othertype 2 diabetes-
dc.subject.othervertebral fracture (VF)-
dc.subject.othervertebral fracture assessment (VFA)-
dc.subject.otherdual energy X-ray absorptiometry (DEXA)-
dc.titlePrevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study-
dc.typeJournal Contribution-
dc.identifier.volume13-
local.bibliographicCitation.jcatA1-
dc.description.notesvan den Bergh, JP (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Maastricht, Netherlands.; van den Bergh, JP (corresponding author), Maastricht Univ Med Ctr MUMC, Dept Internal Med, Maastricht, Netherlands.; van den Bergh, JP (corresponding author), VieCuri Med Ctr, Dept Internal Med, Subdiv Endocrinol, Venlo, Netherlands.-
dc.description.notesjvdbergh@viecuri.nl-
local.publisher.placeAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr832977-
dc.identifier.doi10.3389/fendo.2022.832977-
dc.identifier.pmid35250885-
dc.identifier.isiWOS:000765570600001-
dc.contributor.orcidvan den Bergh, Joop/0000-0003-3984-2232-
local.provider.typewosris-
local.description.affiliation[van Hulten, Veerle; Driessen, Johanna H. M.] Maastricht Univ Med Ctr MUMC, Dept Clin Pharm & Toxicol, Maastricht, Netherlands.-
local.description.affiliation[van Hulten, Veerle; Driessen, Johanna H. M.; van den Bergh, Joop P.] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Maastricht, Netherlands.-
local.description.affiliation[van Hulten, Veerle; Driessen, Johanna H. M.; Schaper, Nicolaas C.; Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schram, Miranda T.; Dagnelie, Pieter C.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.-
local.description.affiliation[Sarodnik, Cindy; Geusens, Piet P. M. M.; Bours, Sandrine P. G.] Maastricht Univ Med Ctr MUMC, Dept Internal Med, Div Rheumatol, Maastricht, Netherlands.-
local.description.affiliation[Schaper, Nicolaas C.; Stehouwer, Coen D. A.; van der Kallen, Carla J. H.; Schram, Miranda T.; van den Bergh, Joop P.] Maastricht Univ Med Ctr MUMC, Dept Internal Med, Maastricht, Netherlands.-
local.description.affiliation[Schaper, Nicolaas C.; Bours, Sandrine P. G.; Dagnelie, Pieter C.] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands.-
local.description.affiliation[Geusens, Piet P. M. M.] Univ Hasselt, Biomed Res Inst, Hasselt, Belgium.-
local.description.affiliation[Webers, Carol A. B.] Maastricht Univ Med Ctr MUMC, Univ Eye Clin Maastricht, Maastricht, Netherlands.-
local.description.affiliation[Dinant, Geert-Jan; Ottenheijm, Ramon P. G.] Maastricht Univ, Dept Family Med, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands.-
local.description.affiliation[Rasmussen, Nicklas H.; Viggers, Rikke] Aalborg Univ Hosp, Steno Diabet Ctr North Jutland, Dept Endocrinol, Aalborg, Denmark.-
local.description.affiliation[Viggers, Rikke] Aalborg Univ, Dept Clin Med, Aalborg, Denmark.-
local.description.affiliation[Schram, Miranda T.] Maastricht Univ Med Ctr MUMC, Heart & Vasc Ctr, Maastricht, Netherlands.-
local.description.affiliation[Dagnelie, Pieter C.] Maastricht Univ, Dept Epidmiol, Maastricht, Netherlands.-
local.description.affiliation[van den Bergh, Joop P.] VieCuri Med Ctr, Dept Internal Med, Subdiv Endocrinol, Venlo, Netherlands.-
local.uhasselt.internationalyes-
item.fullcitationvan Hulten, Veerle; Sarodnik, Cindy; Driessen, Johanna H. M.; Schaper, Nicolaas C.; GEUSENS, Piet; Webers, Carol A. B.; Dinant, Geert-Jan; Ottenheijm, Ramon P. G.; Rasmussen, Nicklas H.; Viggers, Rikke; Stehouwer, Coen D. A.; VAN DER KALLEN, Carla; Schram, Miranda T.; Bours, Sandrine P. G.; Dagnelie, Pieter C. & VAN DEN BERGH, Joop (2022) Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study. In: Frontiers in Endocrinology, 13 (Art N° 832977).-
item.contributorvan Hulten, Veerle-
item.contributorSarodnik, Cindy-
item.contributorDriessen, Johanna H. M.-
item.contributorSchaper, Nicolaas C.-
item.contributorGEUSENS, Piet-
item.contributorWebers, Carol A. B.-
item.contributorDinant, Geert-Jan-
item.contributorOttenheijm, Ramon P. G.-
item.contributorRasmussen, Nicklas H.-
item.contributorViggers, Rikke-
item.contributorStehouwer, Coen D. A.-
item.contributorVAN DER KALLEN, Carla-
item.contributorSchram, Miranda T.-
item.contributorBours, Sandrine P. G.-
item.contributorDagnelie, Pieter C.-
item.contributorVAN DEN BERGH, Joop-
item.validationecoom 2023-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
crisitem.journal.issn1664-2392-
crisitem.journal.eissn1664-2392-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

3
checked on Apr 30, 2024

Page view(s)

28
checked on Sep 7, 2022

Download(s)

56
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.